Powder: -20°C for 3 years | In solvent: -80°C for 1 year
Glaucine has antitussive, antioxidative potential and antiviral activities, it may be an anti-arthritic agent, it can enhance LPS and zymosan-induced IL-10 production. Glaucine can inhibit the migration and invasion of human breast cancer cells by MMP-9 inhibitory activity, attenuating IκBα and NF-κB activities.
Pack Size | Availability | Price/USD | Quantity |
---|---|---|---|
1 mg | In stock | $ 42.00 | |
5 mg | In stock | $ 93.00 | |
10 mg | In stock | $ 147.00 | |
25 mg | In stock | $ 246.00 | |
50 mg | In stock | Inquiry |
Description | Glaucine has antitussive, antioxidative potential and antiviral activities, it may be an anti-arthritic agent, it can enhance LPS and zymosan-induced IL-10 production. Glaucine can inhibit the migration and invasion of human breast cancer cells by MMP-9 inhibitory activity, attenuating IκBα and NF-κB activities. |
Targets&IC50 | PDE4:3.4 µM (Ki) |
Source |
Molecular Weight | 355.43 |
Formula | C21H25NO4 |
CAS No. | 475-81-0 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
DMSO: 30mg/ml(84.41mM)
You can also refer to dose conversion for different animals. More
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
Glaucine 475-81-0 GPCR/G Protein Membrane transporter/Ion channel Metabolism Microbiology/Virology Neuroscience Dopamine Receptor Calcium Channel Influenza Virus Adrenergic Receptor PDE NSC 34396 alkaloid O,O-Dimethylisoboldine PDE4 antioxidative Phosphodiesterase (PDE) NSC-34396 Beta Receptor NSC34396 α-adrenoceptor antiviral inhibit Inhibitor cAMP Ca channels anti-inflammatory anti-arthritic antitussive bronchodilation Ca2+ Ca2+ channels inhibitor